Hiroyuki Watanabe Selected Research

Hiroyuki Watanabe Research Topics

Disease

58	Neoplasms (Cancer) 05/2024 - 01/2003
30	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 05/2005
20	Schizophrenia (Dementia Praecox) 01/2023 - 06/2003
14	Heart Failure 12/2021 - 03/2009
14	Pain (Aches) 01/2021 - 11/2004
13	Amyloid Plaque 11/2020 - 09/2010
11	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2003
11	Psychotic Disorders (Schizoaffective Disorder) 12/2017 - 04/2013
10	Inflammation (Inflammations) 02/2024 - 12/2002
10	Type 2 Diabetes Mellitus (MODY) 11/2021 - 05/2004
9	Aortic Valve Stenosis (Aortic Stenosis) 02/2024 - 07/2013
9	Thrombosis (Thrombus) 01/2024 - 01/2006
9	Treatment-Resistant Schizophrenia 01/2021 - 04/2013
7	Carcinoma (Carcinomatosis) 07/2023 - 01/2002
7	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2016
7	Hypertension (High Blood Pressure) 03/2022 - 01/2012
7	Atrial Fibrillation 08/2021 - 02/2009
7	Cardiomegaly (Heart Hypertrophy) 01/2020 - 03/2007
6	Parkinson Disease (Parkinson's Disease) 10/2022 - 01/2017
6	Dementia (Dementias) 10/2022 - 01/2004
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 12/2011
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2014 - 12/2004
5	Atherosclerosis 08/2023 - 01/2006
5	Pathologic Constriction (Stenosis) 10/2020 - 01/2005
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 04/2002
5	Hypertrophy 01/2019 - 12/2007
5	Obesity 05/2012 - 05/2005
4	Carcinoma in Situ 07/2023 - 01/2017
4	Synucleinopathies 10/2022 - 12/2020
4	Multiple System Atrophy 10/2022 - 12/2020
4	Ischemia 05/2022 - 08/2002
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 11/2010
4	Brain Injuries (Brain Injury) 10/2021 - 01/2020
4	Heart Diseases (Heart Disease) 07/2016 - 02/2009
4	Cognitive Dysfunction 01/2016 - 05/2008
4	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 09/2015 - 11/2010
4	Major Depressive Disorder (Major Depressive Disorders) 01/2015 - 07/2003
4	Peritonitis 10/2008 - 11/2004
3	Multiple Sclerosis 03/2024 - 12/2020
3	Hypersensitivity (Allergy) 02/2024 - 02/2017
3	Chronic Limb-Threatening Ischemia 10/2023 - 01/2020
3	Drug-Related Side Effects and Adverse Reactions 05/2022 - 01/2019
3	Infections 05/2022 - 11/2019
3	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 10/2009
3	Insulinoma 01/2022 - 08/2011
3	Disease Progression 01/2022 - 05/2009
3	Hypoxia (Hypoxemia) 01/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

26	Amyloid (Amyloid Fibrils)IBA 05/2024 - 01/2011
15	Biomarkers (Surrogate Marker)IBA 10/2023 - 06/2003
15	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
11	Dopamine (Intropin)FDA LinkGeneric 12/2017 - 04/2013
10	AntigensIBA 04/2024 - 04/2004
10	Peptides (Polypeptides)IBA 01/2019 - 10/2009
10	Antipsychotic Agents (Antipsychotics)IBA 12/2017 - 11/2003
9	preproenkephalinIBA 01/2018 - 08/2006
7	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 05/2024 - 04/2012
7	SteroidsIBA 07/2023 - 01/2005
7	SynucleinsIBA 10/2022 - 01/2017
7	Opioid Analgesics (Opioids)IBA 10/2021 - 06/2012
7	Carbonic Anhydrase IXIBA 01/2021 - 01/2018
6	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
6	Messenger RNA (mRNA)IBA 08/2020 - 05/2005
6	EnzymesIBA 01/2020 - 01/2003
6	Dynorphins (Dynorphin)IBA 01/2018 - 11/2010
5	Monoclonal AntibodiesIBA 01/2023 - 01/2003
5	AnticoagulantsIBA 08/2021 - 01/2010
5	tau Proteins (tau Protein)IBA 05/2021 - 09/2016
5	Opioid Peptides (Opioid Peptide)IBA 01/2018 - 07/2013
4	Radioisotopes (Radionuclides)IBA 01/2023 - 10/2009
4	Trastuzumab (Herceptin)FDA Link 01/2023 - 01/2017
4	CytokinesIBA 01/2022 - 11/2004
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2005
4	LipidsIBA 12/2020 - 06/2004
4	Islet Amyloid PolypeptideIBA 11/2020 - 08/2014
4	Angiotensin IIIBA 01/2020 - 03/2007
4	benzofuranIBA 05/2018 - 01/2013
4	oxidized low density lipoproteinIBA 04/2016 - 01/2006
4	C-Reactive ProteinIBA 04/2016 - 10/2010
4	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2016 - 04/2013
4	Thallium-201IBA 06/2013 - 03/2004
4	Glucose (Dextrose)FDA LinkGeneric 01/2013 - 05/2004
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2012 - 07/2003
4	Amyloid beta-PeptidesIBA 07/2010 - 03/2009
4	DiglyceridesIBA 01/2007 - 03/2005
3	AlbuminsIBA 04/2024 - 12/2021
3	Bile Pigments (Bilin)IBA 07/2023 - 10/2021
3	LigandsIBA 01/2022 - 01/2015
3	AcidsIBA 01/2022 - 11/2019
3	NeuropeptidesIBA 05/2021 - 09/2015
3	imidazothiadiazoleIBA 01/2021 - 01/2020
3	Gemcitabine FDA Link 01/2021 - 10/2008
3	SulfonamidesIBA 01/2021 - 01/2020

Therapy/Procedure

55	Therapeutics 05/2024 - 05/2002
17	Drug Therapy (Chemotherapy) 05/2022 - 01/2007
7	Transcatheter Aortic Valve Replacement 02/2024 - 07/2013
7	Stents 11/2021 - 09/2007
4	Percutaneous Coronary Intervention 10/2018 - 09/2007
4	Ligation 01/2018 - 11/2004
4	Injections 01/2016 - 04/2013
3	Precision Medicine 06/2021 - 01/2018